Identification of Siglec-1-negative alveolar macrophages with proinflammatory phenotypes in chronic obstructive

Takuya Saito1, Naoya Fujino1, Yorihiko Kyogoku1

  • 1Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Insights

Siglec-1-negative alveolar macrophages (AMs) with a proinflammatory phenotype are increased in chronic obstructive pulmonary disease (COPD). This subset is linked to disease severity and lung function decline in COPD patients.

Area of Science:

  • Immunology
  • Pulmonology
  • Cell Biology

Background:

  • Alveolar macrophages (AMs) drive airway inflammation in chronic obstructive pulmonary disease (COPD).
  • Subpopulations of AMs involved in COPD pathogenesis remain poorly understood.
  • Siglec-1 expression, crucial for bacterial engulfment, is reduced in COPD AMs.

Purpose of the Study:

  • To characterize Siglec-1-negative AM subpopulations in COPD.
  • To investigate the phenotype and clinical relevance of these AM subsets.
  • To determine the association of Siglec-1-negative AMs with COPD progression and outcomes.

Main Methods:

  • Flow cytometry to isolate AM subsets based on Siglec-1 expression and scatter properties (SSC/FSC).
  • RNA sequencing to analyze gene expression profiles of identified subsets.
  • Cytokine analysis to assess inflammatory responses.
  • Correlation analysis with clinical data including exacerbation risk and lung function.

Main Results:

  • A Siglec-1-negative, low scatter (Siglec-1-SSCloFSClo) AM subset was increased in COPD patients.
  • This subset exhibited upregulated proinflammatory pathways and matrix metalloproteases.
  • Siglec-1-negative AMs produced significant levels of TNF-α, IL-6, and IL-8, with heightened responses to viral RNA.
  • Increased Siglec-1-negative AMs in sputum correlated with future exacerbation risk and lung function decline.

Conclusions:

  • A novel Siglec-1-negative AM subset (Siglec-1-SSCloFSClo) displays a proinflammatory phenotype in COPD.
  • This subset exhibits intermediate characteristics between monocytes and mature AMs.
  • The emergence of this proinflammatory AM subset is associated with COPD pathogenesis and poor clinical outcomes.